PCRX — Pacira BioSciences Share News
0.000.00%
Last trade - 00:00- $1.45bn
- $1.56bn
- $726.41m
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
NASDAQ RESUMED AT 08:15 AM
Brief: Viatris Agrees To Acquire Pacira Biosciences, Advancing Its Innovative Medicines Strategy And Becoming A Leader In Non-Opioid Pain Therapies
Advisory: Incorrect alert on Pacira Biosciences' share movement withdrawn
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal (updated)
Viatris to acquire Pacira Biosciences in $1.65 billion deal
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:40 AM
Pacira Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Pacira Q2 revenue slightly beats estimates; cuts FY outlook
Brief: Pacira Biosciences Advances Pcrx-201 Development Program With Successful Transition To Scalable Commercial Manufacturing Process
U.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
U.S. STOCKS ON THE MOVE-Oklo, Fortune Brands, Air Products
Brief: Pacira Biosciences Announces Agreement To Divest Its Iovera° Business To Zimmer Biomet
Pacira rises on deal to sell pain relief device business
Brief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees